Clinical characteristics of the smooth tubercle bacilli ‘Mycobacterium canettii’ infection suggest the existence of an environmental reservoir  by Koeck, J.-L. et al.
Clinical characteristics of the smooth tubercle bacilli ‘Mycobacterium
canettii’ infection suggest the existence of an environmental reservoir
J.-L. Koeck1, M. Fabre2, F. Simon3, M. Daffe´4, E´. Garnotel5, A. B. Matan6, P. Ge´roˆme7, J.-J. Bernatas6, Y. Buisson8 and
C. Pourcel9
1) Laboratoire de biologie clinique, HIA Robert Picque´, Bordeaux, 2) Laboratoire de biologie clinique, HIA Percy, Clamart, 3) Service des maladies infectieuses
et tropicales, HIA Laveran, Marseille, 4) Institute of Pharmacology and Structural Biology, Toulouse, 5) Laboratoire de biologie clinique HIA Laveran,
Marseille, France, 6) Service de lutte anti-tuberculeuse, Centre Paul Faure, Djibouti, 7) Laboratoire de biologie clinique, HIA Desgenettes, Lyon, 8) Institut de
Me´decine Tropicale du Service de Sante´ des Arme´es, Marseille and 9) Universite´ Paris-Sud 11, CNRS, UMR8621, Laboratoire GPMS, Institut de Ge´ne´tique
et Microbiologie, Orsay, France
Abstract
Over a 3-year follow-up, 30 out of the 318 unique Mycobacterium tuberculosis complex isolates recovered in the Republic of Djibouti
had a smooth-type morphology and were Niacine-negative, the characteristics of ‘Mycobacterium canettii’ strains. Unlike M. tuberculosis,
‘M. canettii’ grew on nutrient-poor media at 30C, and possessed characteristic lipids. They were isolated from respiratory and extra-
respiratory sites from patients with typical forms of tuberculosis. Most cases resolved with antibiotic therapy but in two human immu-
nodeﬁciency virus-positive patients ‘M. canettii’ infection led to septicaemia and death. No cases of human-to-human transmission were
observed. The proportion of tuberculosis cases caused by ‘M. canettii’ was higher among French patients than among Djiboutian
patients. Patients with ‘M. canettii’ were signiﬁcantly younger than those with tuberculosis caused by other M. tuberculosis complex
strains. Smooth tubercle bacilli could be misidentiﬁed as non-tuberculous mycobacteria and appear to be limited to the Horn of Africa.
Their characteristics are consistent with the existence of non-human sources of infection.
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Introduction
Tuberculosis (TB) is a serious health problem in the Republic
of Djibouti, with an estimated incidence of 620 per 100 000
persons in 2007 (ranked third in the world) [1]. This
includes refugees from neighbour countries, Somalia and
Ethiopia. TB infections are generally caused by Mycobacterium
tuberculosis and occasionally by Mycobacterium bovis. Primary
culture of M. tuberculosis on Lo¨wenstein–Jensen (LJ) and
Coletsos media usually results in characteristic colonies with
a rough texture and a typical cord aspect upon microscopic
examination. These features enable microbiologists to distin-
guish M. tuberculosis from other mycobacteria species. This is
particularly important in developing countries, where bio-
chemical or molecular techniques may not be available.
The Republic of Djibouti appears to be an exceptional
place in terms of TB caused by ‘Mycobacterium canettii’, a
highly unusual tubercle bacillus related to the M. tuberculosis
complex (MTBC). ‘M. canettii’ was ﬁrst isolated from a
20-year-old French farmer suffering from pulmonary tubercu-
losis by G. Canetti in 1969. Since then, this strain has been
isolated on rare occasions from patients who lived or were
presumably infected in East Africa [2–5] Molecular analysis of
43 smooth isolates, mostly originating from the Republic of
Djibouti, by Multiple locus Variable Number of Tandem
Repeats analysis and by analysis of the Direct Repeat struc-
ture showed that the taxon was genetically heterogeneous
[6]. The RD12can region ﬁrst reported to be deleted in two
‘M. canettii’ isolates was later shown to be intact in other
smooth isolates [7] whereas the existence of mosaicism
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suggested that ‘M. canettii’ had exchanged genetic material
with another mycobacteria species [8]. In this article we
report clinical, epidemiological and microbiological data that
conﬁrm the existence of a single ‘M. canettii’ taxon and that
suggest the existence of a reservoir of ‘M. canettii’ in the
Republic of Djibouti.
Patients and Methods
Ethics statement
In the present retrospective study two categories of bacterial
isolates were analysed. Some were collected from sputum as
part of the patients’ usual care and therefore approval by an
ethics committee was not needed. The second category of
strains was isolated from lymph nodes as part of a study for
which approval of a local ethics committee (the Paul Faure
Centre Ethics Committee) had been obtained [9]. A transla-
tor speaking multiple languages (Somalian, Arabic, Affar)
informed the patients of the study and asked for their con-
sent. The consent was given in writing, mainly by ﬁngerprint-
ing as most of the patients were illiterate. None of the
patients refused the specimen collection. Diagnostic methods
are usually very basic and discontinuous in Djibouti but, dur-
ing the work on lymph nodes, state-of-the-art methods were
used and the patients beneﬁted from complete therapeutic
treatment and follow-up. The patient information and clinical
data reported in the present work were rendered anony-
mous (removing the possibility of tracing the actual patient).
Consequently, written informed consent by the patients for
the clinical information to be used for research was not
asked. This is the accepted procedure for the Paul Faure
Centre Ethics Committee in the Republic of Djibouti.
Patients
The majority of patients included in this study attended one
of the two medical centres in Djibouti, Republic of Djibouti.
The Paul Faure Anti-tuberculosis Centre (PFC) cares for Dji-
boutian patients with suspected TB. Within this centre, a
study was performed between January and April 1999 to
evaluate antibiotic resistance patterns [10] and to conﬁrm
the performance of the Ampliﬁed Mycobacterium Tuberculo-
sis Direct Test for the rapid diagnosis of lymph node tuber-
culosis [9]. The study involved collecting mycobacteria
culture-positive lymph nodes by ﬁne-needle aspiration in
patients suspected of having TB, as recommended by the
National TB Programme of Djibouti. Therefore, no additional
invasive examination was made because of the study. Biologi-
cal tests that were performed on the bacterial strains
resulted in more appropriate and faster implementation of
the patient’s treatment. When a case was diagnosed, an
investigation of the close family members was quickly insti-
tuted and all the suspected cases were called for clinical
examination. The French Bouffard Military Hospital (BMH)
cares for French and Djiboutian soldiers and their families.
All patients with a positive culture for mycobacteria between
January 1998 and June 2001 were retrospectively included in
the study. Eighty-ﬁve per cent of these patients were aged
more than 15 years.
Sample processing and identiﬁcation test
Direct smear examination was performed systematically.
Acid-fast bacilli were detected in biological samples by aur-
amine staining. Positive results were conﬁrmed by Ziehl–
Neelsen staining. The lymph node samples collected at PFC
were cultured in Mycobacterial Growth Indicator Tubes
(MGIT; Becton-Dickinson, Le Pont de Claix, France) and on
solid medium (LJ and Coletsos slants). The strains from
patients at BMH were isolated on solid medium only. All the
isolates were sent to the Percy Military Hospital for further
characterization. Bacteria belonging to the MTBC were iden-
tiﬁed by 16S ribosomal RNA analysis using the Ampliﬁed
Mycobacterium Tuberculosis Direct Test (Gen-Probe-bio-
Merieux, Lyon, France) which does not allow differentiation
of ‘M. canettii’ from the other members of the MTBC.
Conventional biochemical procedures were applied [11]
and samples were also tested using the AccuProbe assay
(Gen-Probe-bioMerieux). For selected strains, standardized
dilutions of colonies were simultaneously cultured on both
LJ and trypticase-soy plates (BioRad, Marnes la Coquette,
France) at 37C and 30C, for each medium. Middlebrook
7H10 and 7H11 media were also used.
Drug susceptibility testing
Susceptibility of the isolates to isoniazid (0.2 g/L), rifampicin
(40 g/L), streptomycin (4 g/L), ethambutol (2 g/L), cycloserine
(10 g/L), capreomycin (10 g/L), kanamycin (10 g/L) and thiac-
etazone (2 g/L), was determined by the proportion method
on LJ medium [12]. Resistance to pyrazynamide was mea-
sured in both liquid medium (BACTEC 960) and LJ medium.
Susceptibility to trimethoprim–sulphamethoxazole, amikacin,
ciproﬂoxacin and oﬂoxacin was tested by the disc diffusion
method, using commercially available antibiotic discs (BioRad)
[13]. An isolate was considered to be susceptible to one of
these molecules when the inhibition diameter was larger
than 19 mm [13].
Lipid analysis
Cellular lipids were extracted with chloroform/methanol and
then analysed as previously described [14]. The fatty acid
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methyl esters arising from saponiﬁcation of delipidated cells
and lipid extracts were analysed by thin-layer chromatogra-
phy and gas–liquid chromatography [15]. The examined ref-
erence strains included M. bovis BCG (bacillus Calmette–
Gue´rin), the original ‘M. canettii’ strain (CIPT 140010059)
and a clinical M. tuberculosis strain.
Statistical analysis
Statistical analyses were performed with EPI INFO 2002 (Divi-
sion of Public Health Surveillance and Informatics, Epidemiol-
ogy Program Ofﬁce, Centers for Disease Control and
Prevention, Atlanta, GA, USA). Categorical variables were
compared using Fisher’s exact test and continuous variables
using the Wilcoxon rank-sum test. All tests were two tailed.
p values of £0.05 were considered signiﬁcant.
Results
Bacteriological data
From 85 patients, the PFC isolated 85 Mycobacterium cul-
tures which all hybridized with the MTBC DNA probe. Sev-
enty-nine isolates were identiﬁed as M. tuberculosis, one as
Mycobacterium africanum and one as M. bovis. Four isolates
(4.7%) formed colonies with a pale beige, smooth and glossy
aspect (smooth-type tubercle bacilli (SmTB)) characteristic of
the known ‘M. canettii’ strains (Fig. 1). The BMH isolated 265
Mycobacterium cultures from 258 patients in the period from
1998 to 2001. Hybridization with the MTBC DNA probe
was observed for 233 isolates of 233 patients. The other 32
isolates from 25 patients were non-tuberculous mycobacte-
ria. Among the 233 MTBC isolates, 207 were identiﬁed as
M. tuberculosis, and 26 were of the SmTB type (11.2%).
Molecular identiﬁcation of ‘M. canettii’ identity was provided
by observation of the pncA gene A138G SNP (Fabre M,
Hauck Y, Soler C et al. unpublished data) [16]. Table 1
shows the annual distribution of SmTB isolates in BMH
according to the site of isolation. SmTB isolates were recov-
ered from 17 respiratory samples 11 from sputum and six
from gastric ﬂuids, eight lymph nodes and one peritoneal
liquid sample. A smear result positive for acid-fast bacilli was
found in 50% and 56% of respiratory samples, and 25% and
29% of extrapulmonary samples for M. tuberculosis and
‘M. canettii’, respectively, which is not signiﬁcantly different.
In the years 2001–2007, ten additional SmTB isolates were
recovered in BMH, representing about 8% of the total
MTBC isolates for this period. Overall, the proportion of
SmTB isolates did not differ between pulmonary and extra-
pulmonary samples. All SmTB isolates from Djibouti were
shown to be tolerant to thiophene-2-carboxylic acid hydra-
zide (2 g/L), positive for nitrate reductase, urease and ther-
molabile catalase, but negative for niacin and b-glucosidase.
Phenotypic characteristics
On LJ medium, using the standardized inocula for the pro-
portion method, the mean time until appearance of count-
able colonies was 23 days (range: 18–25 days) for
M. tuberculosis and 22 days (range: 16–25 days) for SmTB iso-
lates. In contrast, culture in liquid medium was twice as fast
for SmTB isolates compared with the other MTBC isolates.
Microscopic examination of Ziehl–Neelsen-stained SmTB col-
onies showed a homogeneous distribution of the bacilli,
which appeared as singlets or aggregated in small clumps
instead of the cord-like aggregates usually seen with the
rough M. tuberculosis strains.
The culture characteristics of ten SmTB isolates (ﬁve
group A isolates, four group B isolates and Percy 32, accord-
ing to molecular genetic patterns [6]) on trypticase-soy agar
were investigated. SmTB strain colonies measured 2–4 mm
in diameter after 3 weeks at 37C or 4 weeks at 30C. In the
(a) (b)
FIG. 1. Colonies of (a) a smooth-type
Mycobacterium tuberculosis and (b) an
M. tuberculosis stricto sensu strain after
growth on Middlebrook 7H11 agar.
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same conditions, using an identical inoculum, M. tuberculosis
H37Rv and ﬁve clinical isolates of M. tuberculosis isolated
during the same period at Djibouti, failed to grow or only
grew very slightly.
As the type-speciﬁc phenolic glycolipid was previously
detected in ‘M. canettii’ [14], the lipid cell wall composition
was studied to look for differences between the SmTB
strains. The fatty methyl ester proﬁles of ten SmTB strains
(seven group A, three group B) were similar to those of
MTBC; mycolates were composed of a-methoxymycolates
and ketomycolates, and pyrolytic product was identiﬁed as
hexacosanoate [15]. The type-speciﬁc phenolic glycolipid was
detected in the lipid extracts of all the SmTB strains studied
independently of the genotype or other molecular character-
istics, but not in those of the M. tuberculosis reference strains
[14]. SmTB isolates were signiﬁcantly more susceptible to
isoniazid and trimethoprim–sulphamethoxazole (1.25 g/L
trimethoprime + 23.75 g/L sulphamethoxazole), and more
resistant to streptomycin than the MTBC isolates (Table 2).
They were all resistant to 100 g/L pyrazynamide when
cultured in liquid medium (BACTEC 960) but susceptible to
200 g/L pyrazynamide on LJ medium.
Descriptive and analytic study of patients with TB caused by
an SmTB strain
We compared the age, sex and human immunodeﬁciency
virus (HIV) status of PFC patients from which SmTB strains
were isolated and from patients with regular MTBC strains.
Patients with SmTB strains were signiﬁcantly younger than
those with MTBC strains but there were no differences with
respect to gender or HIV status (Table 3). Among BMH
patients, mostly French or Djiboutian adults, we assessed
whether geographic origin affected the risk of having TB
caused by an SmTB strain (Table 4). The proportion of TB
cases caused by an SmTB strain was signiﬁcantly higher
among French expatriates (three of ﬁve) than among the Dji-
boutian patients (23/228) (Fisher’s exact test, p 0.01). How-
ever, because of the small size of the French sub-sample this
result must be interpreted with caution. The three French
patients with TB caused by an SmTB strain included a
36-year-old member of the French Foreign Legion (case pre-
viously reported [4]), a 35-year-old woman and a 5-year-old
child, all vaccinated with BCG. In one case an abscess from
which an SmTB strain was isolated developed within
4 months of arrival in Djibouti. All three French patients
were infected by a group A strain [6].
Clinical and radiological signs did not differ between TB
cases caused by SmTB strains or MTBC strains. In general
no multi-site infection was observed, except in two HIV-
positive patients in whom the ‘M. canettii’ infection led
to septicaemia and death. The only common risk factor
TABLE 1. Distribution of smooth-type strains in Bouffard
hospital according to year and site of isolation
Year
No. of pulmonary
cases
No. of extrapulmonary
cases
% smooth-type
strainsTotal Smooth-type Total Smooth-type
1998 38 6 24 3 14.5
1999 30 3 22 1 7.7
2000 42 6 25 3 13.4
2001a 40 2 12 2 7.7
Total 150 17 83 9 11.2
aFrom January to June.
TABLE 2. Drug resistance of SmTB and Mycobacterium
tuberculosis strains
Drug
No. of resistant strains/No. of
tested strains
p-valueSmooth-type M. tuberculosisa
Isoniazid 0/30 39/281 0.02
Rifampicin 0/30 17/281 0.39
Ethambutol 0/30 16/281 0.38
Streptomycin 20/30 45/281 <0.0001
Pyrazinamideb 26/26 1/212 <0.0001
Trimethoprim–
sulphamethoxazole
4/29 26/26 <0.0001
Cycloserine 0/9 0/53 1
Capreomycin 0/10 1/63 1
Kanamycin 0/9 2/57 1
Thiacetazone 0/13 9/73 0.34
Amikacin 0/12 1/26 1
Ciproﬂoxacin 0/12 1/26 1
Oﬂoxacin 0/12 0/26 1
aTwo hundred and four strains from Bouffard French Military Hospital, and 77
strains from Paul Faure Anti-tuberculosis Centre.
bAt a concentration of 100 g/L in BACTEC 960.
TABLE 3. Age, sex and HIV status of patients with tuber-
culosis caused by an ‘Mycobacterium canettii’ strain or a
Mycobacterium tuberculosis (non-smooth-type) strain,
according to the centre of admission
Characteristic
Paul Faure Centre
Bouffard
hospital
Smooth-
typea
(n = 4)
M. tuberculosis
(n = 77) p-value
Smooth-
type
(n = 26)
Age
No. available 4 77 0.032b 16
Range 4–18 1–64 4–63
Mean 10.5 23 31
Median 10 21 32
Sex
No. available 4 77 1 26
Male sex 2 32 16
Human immunodeﬁciency virus status
No. available 4 65 1 16
No. seropositive 0 11 3
aSmooth-type M. tuberculosis complex strains.
bp determined with Wilcoxon rank-sum test.
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(occupational or residential) found was living in the Republic
of Djibouti or East African countries; none of the patients
was reported to have come into contact with an infected
person. However, the local sanitary conditions and the
delayed diagnosis did not allow us to investigate case con-
tacts completely.
Patients with lymph node TB were treated with rifampicin,
isoniazid and pyrazynamide for 2 months, and then with rif-
ampicin and isoniazid for the following 2 months [10].
Patients with pulmonary TB were given rifampicin, isoniazid,
pyrazynamide and ethambutol for 2 months, and then rifam-
picin and isoniazid for the following 4 months. Most treated
patients responded well to treatment, but two patients did
not come back for treatment after their ﬁrst visit to the hos-
pital, and three died of septicaemia.
Discussion
The various observations in this study conﬁrm that this large
collection of SmTB strains appears to share important bio-
chemical and structural characteristics observed in the origi-
nal strain isolated by Canetti and further characterized by
van Soolingen et al. [2]. Interestingly, most of the SmTB
isolates studied here were susceptible to trimethoprim–sul-
phamethoxazole, under conditions where M. tuberculosis
shows resistance. Hence, and even though recent work has
demonstrated that M. tuberculosis is not naturally resistant to
this drug at a concentration of ‡ 1/19 lg/mL [17], SmTB
isolates seem to show a different behaviour that deserves
further investigation.
The geographical restriction of ‘M. canettii’ isolates and
contrasting genetic diversity are characteristics compatible
with a non-human reservoir, as previously proposed [6]. The
smooth aspect of the colonies is probably the result of a
particular membrane structure that could favour growth in
unfavourable conditions by protecting them, for instance,
from desiccation or by providing a reservoir for certain
nutrients. It has been hypothesized that mycobacteria were
initially found in soil and water and that some species
evolved to live in mammals [18,19]. Properly designed epide-
miology studies are essential to rule-out inter-human trans-
mission of ‘M. canettii’ and to question the existence of
another reservoir. It is of interest to note that ‘M. canettii’,
the possible ancestor of the MTBC, is found almost exclu-
sively in the Horn of Africa where TB is thought to have
emerged about 40 000 years ago, coinciding with the expan-
sion of human population out of Africa [20].
TABLE 4. Characteristics of the strains
Strain ID Patient nat.a Age Gender
Year of
isolation TB siteb MLVA groupc Aliasd
1 percy3a DJ 8 f 1998 Pulm A 19990516
2 percy6 FR 35 f 1998 Pulm A 19990515
3 percy8 FR 4 f 1998 LN A 19990161
4 percy21a FR 36 m 1998 Pulm A 19990160
5 percy21b DJ UNe f 2000 UN A 20000342
6 percy26 DJ 18 f 1999 LN A 19991708
7 percy29a ETH 34 f 1999 Pulm A 19990589
8 percy74 DJ UN m 2001 Pulm A 20010389
9 percy99c DJ 22 m 1999 Pulm A 19991704
10 percy150 DJ UN m 2000 Pulm A 20001049
11 percy156 DJ 27 m 2001 LN A 20010933
12 percy189b DJ UN m 2000 Pulm A 20001248
13 percy199b DJ UN f 2000 PerL A 20001247
14 percy205 DJ 63 m 2000 Pulm A 20001246
15 percy206 DJ UN m 2000 Pulm A 20001245
16 percy212 DJ 32 m 1998 LN A 19981514
17 percy245b DJ UN f 2000 LN A 20010188
18 percy246 DJ UN m 2001 LN A 20010390
19 percy257 DJ 40 f 1998 LN A 19980862
20 percy32 DJ 13 m 1999 LN 19990711
21 percy79 DJ UN m 2001 Pulm 20010391
22 percy94 DJ 42 m 1999 Pulm B 19991705
23 percy213 DJ 20 m 1998 Pulm B 19980864
24 percy214 DJ 27 f 1998 Pulm B 19980863
25 percy258 DJ 40 m 1998 Pulm B 19980865
26 percy25 DJ 7 m 2000 LN 19991709
27 percy65 DJ 4 f 1999 LN
28 percy89 ETH UN f 2000 LN 20000587
29 percy99b DJ UN m 2000 Pulm 20000473
30 percy157 DJ UN m 1999 Pulm
aPatient nationality: DJ, Djibouti, FR, France, ETH, Ethiopia, ERI, Eritrea, SOM, Somalia.
bPulm, pulmonary, LN, lymph node, PerL, peritoneal liquid.
cAs in Fabre et al. [6]; MLVA, Multiple locus Variable Number of Tandem Repeats analysis.
dStrain name as in Gutierrez et al. [7].
eUN, unknown.
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The incidence of TB caused by SmTB strains is higher in
children or expatriates than in the rest of the population. A
gender bias in TB is usually not observed in children [21]. If
speciﬁc antigens exist in SmTB strains, it is possible that chil-
dren and foreigners who had not been in previous contact
with such strains or other similar as yet unknown environ-
mental mycobacteria do not possess appropriate immunity,
and are consequently more susceptible. Alternatively, for-
eigners may be more exposed to SmTB strains than to
MTBC strains if the source of contamination and the reser-
voir differ.
In summary, a combined clinical and phenotypic investiga-
tion of a large collection of ‘M. canettii’ isolates indicates that
this is a single taxon. Clinical ‘M. canettii’ disease is identical
to that caused by MTBC members, although it tends to pref-
erentially affect children and foreigners in the Horn of Africa.
Aside from smooth colony morphology, ‘M. canettii’ isolates
are characterized by trimethoprim–sulphamethoxazole sus-
ceptibility, growth on trypticase-soy media and a shorter
generation time in liquid medium. The latter two factors may
allow the bacteria to survive in environmental reservoirs.
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